Tobacco Packaging, Green Tech, University IP On Plate Of WTO IP Committee 20/02/2014 by Catherine Saez, Intellectual Property Watch 1 Comment Technology transfer for green technologies, and the compliance with international trade rules of plain packaging for tobacco products will once again be on the agenda of the World Trade Organization committee on intellectual property next week. A new agenda item on university technology partnerships is also expected to be discussed.
3D Printing Will Cost The World USD100 Billion, Says Study 19/02/2014 by Julia Fraser for Intellectual Property Watch 1 Comment A recent report predicts the loss of at least $100 billion per year in intellectual property globally by 2018 as a result of 3D printing.
Battles Over Patents: Is India Changing The Rules Of The Game? 18/02/2014 by Ranjitha Balasubramanyam for Intellectual Property Watch 4 Comments Over the last couple of years, news of pharmaceutical patents and India’s attempts to protect and manage its market has caught the attention of intellectual property observers everywhere and the pharmaceutical industry in particular.
Paper Makes Recommendations For Exhaustion Of IP Rights 17/02/2014 by Julia Fraser for Intellectual Property Watch 1 Comment A recent paper issued by the International Centre for Trade and Sustainable Development (ICTSD) compares existing exhaustion policies and makes recommendations for countries in the process of adopting their own regimes in this area. These have the potential to contribute to economic and social development, innovation and the protection of user rights globally, it said.
Biopharma Industries, Others Urge Caution In US Patent Reform 12/02/2014 by William New, Intellectual Property Watch Leave a Comment A coalition of large and small companies and organisation – including the leading trade associations for the US pharmaceutical and biotechnology industries – has asked the US Congress to use caution in rewriting patent laws so as not to cause unintended harm to their ability to innovate.
WHO, IFRC Tap Swiss Federal Funds For New Buildings 12/02/2014 by Intellectual Property Watch Leave a Comment The World Health Organization and International Federation of the Red Cross and Red Crescent have received approval of the Swiss Federal Council to receive millions of Swiss francs in loans for the purpose of planning new buildings in Geneva.
DNDi Director: ‘Reality Check’ Needed For Neglected Diseases 11/02/2014 by Intellectual Property Watch 2 Comments Research and development into neglected diseases – those predominately affecting poorer populations and for which there is little commercial incentive – is undergoing “remarkable advances and rude set-backs,” says Bernard Pécoul, executive director of the Drugs for Neglected Diseases initiative (DNDi). Now, governments need to show stronger leadership in bringing about long-term solutions, he said.
Alert: Pharma IPR 2014 Conference In Mumbai, 26-28 February 10/02/2014 by Intellectual Property Watch Leave a Comment Dear Subscribers, CPhI’s 3rd Annual Pharma IPR 2014 conference to take place from 26-28 February, 2014 in Mumbai, India will have techno-legal experts from over 10+ regions speaking on the recent case studies on global Pharma and Biopharma patent laws. Among them, Jeffery Alan Hovden, Partner, Robins, Kaplan, Miller & Ciresi LLP from US will be speaking on critical developments in US pharma patent law in the year 2013 which have affected pharma and biopharma industry. He will also share best strategies on how Indian generic-drug and biologics enterprises need to go forward with their US-related projects. Some of the critical concerns he is planning to address include: Which pharmaceutical and diagnostic compounds and processes can even obtain a US patent? Whether the new, cheap and fast patent-challenge procedures are right for Indian companies in the life-sciences area? How to avoid paying the attorney fees for the other side in US litigation and indeed, how an Indian company might turn the tables and have the other side pay the company’s attorney fees? You can view his insights on “US Patent Law in 2013: Winds of Change” by clicking here. To optimise interactions with the audience, he and other global techno-legal experts would also be available in query handling sessions as well as one-on-one meetings, to discuss your concerns related to the US patent system. Click here to go through the detailed programme agenda. You can read more about the conference speakers here. To be a part of this exclusive event, please contact the organisers at +91 (22) 6172 7001 / conferences-india@ubm.com, or register online and take advantage of the special offers for you as you are our subscribers. P.S. You may find one of his earlier presentations on “From Small to Big: Some useful points in the coming shift from customary drugs to biologics” interesting – View the presentation here
WIPO Patent Law Committee Agrees On Studies, Seminars, Website Updates 01/02/2014 by William New, Intellectual Property Watch Leave a Comment Members of the World Intellectual Property Organization patent law committee this week bridged significant differences and agreed on a range of activities for future work, each with their own goals for the international patent system in mind.
MSF: AstraZeneca Pullout Of Neglected Disease R&D Proof System Broken 31/01/2014 by Intellectual Property Watch Leave a Comment Following news reports that pharmaceutical producer AstraZeneca will end its spending on early stage research and development for tuberculosis, malaria and neglected tropical diseases, Médecins Sans Frontières issued a statement saying the move is further proof that substantive change to the global pharmaceutical R&D system is needed.